BlackRock Inc. increased its stake in shares of Exponent, Inc. (NASDAQ:EXPO) by 41,234.4% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 3,080,242 shares of the business services provider’s stock after buying an additional 3,072,790 shares during the period. BlackRock Inc. owned about 11.71% of Exponent worth $183,428,000 as of its most recent SEC filing.
Several other institutional investors also recently made changes to their positions in the stock. Thrivent Financial for Lutherans raised its stake in Exponent by 5.1% in the fourth quarter. Thrivent Financial for Lutherans now owns 13,870 shares of the business services provider’s stock valued at $836,000 after buying an additional 670 shares during the last quarter. Nationwide Fund Advisors raised its stake in Exponent by 4.8% in the first quarter. Nationwide Fund Advisors now owns 159,560 shares of the business services provider’s stock valued at $9,502,000 after buying an additional 7,296 shares during the last quarter. Bank of Montreal Can raised its stake in Exponent by 21.8% in the first quarter. Bank of Montreal Can now owns 3,209 shares of the business services provider’s stock valued at $192,000 after buying an additional 575 shares during the last quarter. Louisiana State Employees Retirement System raised its stake in Exponent by 1.0% in the first quarter. Louisiana State Employees Retirement System now owns 10,400 shares of the business services provider’s stock valued at $619,000 after buying an additional 100 shares during the last quarter. Finally, State Street Corp raised its stake in Exponent by 8.1% in the fourth quarter. State Street Corp now owns 573,433 shares of the business services provider’s stock valued at $34,578,000 after buying an additional 43,132 shares during the last quarter. Institutional investors own 90.22% of the company’s stock.
Shares of Exponent, Inc. (NASDAQ EXPO) opened at 66.00 on Friday. The company has a market cap of $1.71 billion, a price-to-earnings ratio of 36.69 and a beta of 0.60. Exponent, Inc. has a 1-year low of $48.42 and a 1-year high of $68.30. The company’s 50-day moving average is $59.23 and its 200 day moving average is $59.06.
Exponent (NASDAQ:EXPO) last posted its earnings results on Tuesday, July 18th. The business services provider reported $0.51 EPS for the quarter, beating analysts’ consensus estimates of $0.41 by $0.10. The business had revenue of $84.10 million for the quarter, compared to the consensus estimate of $79.30 million. Exponent had a net margin of 15.94% and a return on equity of 16.52%. The company’s revenue for the quarter was up 14.7% on a year-over-year basis. During the same quarter last year, the firm posted $0.38 EPS. Equities analysts anticipate that Exponent, Inc. will post $1.90 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, September 22nd. Shareholders of record on Friday, September 1st will be given a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 1.27%. The ex-dividend date is Wednesday, August 30th. Exponent’s dividend payout ratio (DPR) is 43.52%.
EXPO has been the topic of several research reports. Cantor Fitzgerald reissued an “overweight” rating and set a $69.00 price objective (up previously from $64.00) on shares of Exponent in a research note on Saturday, April 22nd. Zacks Investment Research lowered shares of Exponent from a “buy” rating to a “hold” rating in a research note on Wednesday, April 19th. BidaskClub lowered shares of Exponent from a “sell” rating to a “strong sell” rating in a research note on Tuesday, June 27th. Finally, ValuEngine raised shares of Exponent from a “sell” rating to a “hold” rating in a research note on Thursday.
About Exponent
Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO).
Receive News & Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
